As prescription oral chemotherapies have become a common form of cancer treatment, some patients were paying more than $10,000 a year for medications. A new study finds that efforts to cap prescription drug spending are yielding significant out-of-pocket savings for these patients.
Researchers at the University of Michigan Health Rogel Cancer Center have uncovered a key reason why a typically normal protein goes awry and fuels cancer. They found the protein NSD2 alters the function of the androgen receptor, an important regulator of normal prostate development.
The American Society for Radiation Oncology (ASTRO) announced today the seven studies to be highlighted in the 2024 ASTRO Annual Meeting press program. Researchers will discuss their findings in news briefings held September 30 and October 1 at the Walter E. Washington Convention Center in Washington, D.C. and via live webcast.
The UCSF Helen Diller Family Comprehensive Cancer Center announced today that the UCSF Prostate Cancer Program is the recipient of the National Cancer Institute’s (NCI) Specialized Programs of Research Excellence (SPORE) grant for prostate cancer.
Adelaide researchers are calling for general practitioners to take a more proactive approach towards addressing erectile dysfunction (ED) and lower urinary tract symptoms (LUTS), in light of new findings suggesting these conditions may be linked to underlying cardiometabolic disorders. A study, recently published in the Journal of Men’s Health, led by the University of Adelaide’s Professor Gary Wittert and Dr Sam Tafari from SA Health with funding from The Hospital Research Foundation Group, highlighted the importance of screening for urinary symptoms in men.
David M. Golombos, MD, urologic oncologist in the Urologic Oncology Program at Rutgers Cancer Institute and RWJBarnabas Health, New Jersey’s only NCI-designated Comprehensive Cancer Center, shares what men need to know about prostate cancer and screening.
The groundbreaking ChatGPT chatbot shows potential as a time-saving tool for responding to patient questions sent to the urologist's office, suggests a study in the September issue of Urology Practice®, an Official Journal of the American Urological Association (AUA). The journal is published in the Lippincott portfolio by Wolters Kluwer.
The anti-cancer drug olaparib may be effective in treating biochemically recurrent prostate cancer without accompanying hormone therapy for men who have mutations in genes such as BRCA2, according to results of a phase II clinical trial of 51 patients conducted at the Johns Hopkins Kimmel Cancer Center and three other sites.
Scientists at the Icahn School of Medicine at Mount Sinai have identified a new class of RNAs packed into tiny particles known as extracellular vesicles (EVs) that could revolutionize how cancer and other diseases are diagnosed. The team found that these molecules undergo changes when cancer is present, suggesting their potential as biomarkers for detecting prostate cancer or as targets for therapy.
Study: Living in Disadvantaged Neighborhoods Influences Stress-Related Genes, Which May Contribute to Aggressive Prostate Cancer in African American Men
Analysis of men seen at a specialist clinic provides new insights into the classification of Peyronie's disease (PD) subtypes, according to a report in the September issue of The Journal of Urology®, an Official Journal of the American Urological Association (AUA). The journal is published in the Lippincott portfolio by Wolters Kluwer.
Below are summaries of recent Fred Hutch Cancer Center research findings, patient stories and other news.
New Corewell Health™ research suggests an MRI scan can help predict whether patients with intermediate-risk prostate cancer (cancer confined to the entire prostate) may have more aggressive cancer in five years.
A new Australian study reveals who is most at risk of having hernia repair surgery, one of the most common medical conditions and surgical operations performed in hospitals worldwide.
MAYWOOD, IL – Newsweek and Statista are proud to announce that Gopal Gupta, MD affiliated with Loyola Medicine has earned a position in the America's Best Prostate Cancer Surgeons 2024 list. This is an exclusive list of only 150 doctors in the country. Congratulations on this achievement! In an era of informed decision-making, it is increasingly important for patients to make well-founded choices about which doctor to consult for their specific condition.
Mental health screenings must be incorporated in routine prostate cancer diagnoses say University of South Australia researchers. The call follows new research that shows men need more supports both during and immediately after a diagnosis of prostate cancer.
RSS
Medicine keyboard_arrow_right
Sciencekeyboard_arrow_right
Life keyboard_arrow_right
Business keyboard_arrow_right
Journal News keyboard_arrow_right
By Location keyboard_arrow_right
Meetings, Grants, and Events keyboard_arrow_right
